These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31239720)

  • 1. Enhancing the antibacterial activity of polymyxins using a nonantibiotic drug.
    Krishnamurthy M; Lemmon MM; Falcinelli EM; Sandy RA; Dootz JN; Mott TM; Rajamani S; Schaecher KE; Duplantier AJ; Panchal RG
    Infect Drug Resist; 2019; 12():1393-1405. PubMed ID: 31239720
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
    Kim SJ; Jo J; Kim J; Ko KS; Lee W
    Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescuing the Last-Line Polymyxins: Achievements and Challenges.
    Nang SC; Azad MAK; Velkov T; Zhou QT; Li J
    Pharmacol Rev; 2021 Apr; 73(2):679-728. PubMed ID: 33627412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity.
    Patil NA; Ma W; Jiang X; He X; Yu HH; Wickremasinghe H; Wang J; Thompson PE; Velkov T; Roberts KD; Li J
    J Med Chem; 2023 Feb; 66(4):2865-2876. PubMed ID: 36745479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro polymyxin activity against clinical multidrug-resistant fungi.
    Yousfi H; Ranque S; Rolain JM; Bittar F
    Antimicrob Resist Infect Control; 2019; 8():66. PubMed ID: 31044071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
    Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
    [No Abstract]   [Full Text] [Related]  

  • 8. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of polymyxin resistance through the food chain, the global crisis.
    Ray M; Manjunath A; Halami PM
    J Antibiot (Tokyo); 2022 Apr; 75(4):185-198. PubMed ID: 35079146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Polymyxin Resistance.
    Moffatt JH; Harper M; Boyce JD
    Adv Exp Med Biol; 2019; 1145():55-71. PubMed ID: 31364071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens.
    Tran TB; Wang J; Doi Y; Velkov T; Bergen PJ; Li J
    Front Microbiol; 2018; 9():721. PubMed ID: 29706941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxin Resistance in Gram-negative Pathogens.
    Srinivas P; Rivard K
    Curr Infect Dis Rep; 2017 Sep; 19(11):38. PubMed ID: 28895051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions.
    Mohapatra SS; Dwibedy SK; Padhy I
    J Biosci; 2021; 46(3):. PubMed ID: 34475315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Strategy Targeting Polymyxin-Resistant Gram-Negative Pathogens: Polymyxin B in Combination with the Selective Serotonin Reuptake Inhibitor Sertraline.
    Hussein M; Schneider-Futschik EK; Paulin OKA; Allobawi R; Crawford S; Zhou QT; Hanif A; Baker M; Zhu Y; Li J; Velkov T
    ACS Infect Dis; 2020 Jun; 6(6):1436-1450. PubMed ID: 32427476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant
    Wickremasinghe H; Yu HH; Azad MAK; Zhao J; Bergen PJ; Velkov T; Zhou QT; Zhu Y; Li J
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33918040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria.
    Yin J; Meng Q; Cheng D; Fu J; Luo Q; Liu Y; Yu Z
    Appl Microbiol Biotechnol; 2020 May; 104(9):3771-3780. PubMed ID: 32157424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxins-Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment.
    Dai C; Wang Y; Sharma G; Shen J; Velkov T; Xiao X
    Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32526966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxins for CNS infections: Pharmacology and neurotoxicity.
    Velkov T; Dai C; Ciccotosto GD; Cappai R; Hoyer D; Li J
    Pharmacol Ther; 2018 Jan; 181():85-90. PubMed ID: 28750947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.